4//SEC Filing
Szyman Catherine M. 4
Accession 0001225208-24-008339
CIK 0001099800other
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 7:10 PM ET
Size
6.5 KB
Accession
0001225208-24-008339
Insider Transaction Report
Form 4
Szyman Catherine M
CVP, Critical Care & Vascular
Transactions
- Tax Payment
Common Stock
2024-09-03$69.96/sh−5,530$386,879→ 81,287.437 total - Award
Common Stock
2024-09-03+10,910→ 86,817.437 total
Footnotes (1)
- [F1]These restricted stock units were granted on September 3, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are 100% vested and exercisable on the grant date.
Documents
Issuer
Edwards Lifesciences Corp
CIK 0001099800
Entity typeother
Related Parties
1- filerCIK 0001438538
Filing Metadata
- Form type
- 4
- Filed
- Sep 2, 8:00 PM ET
- Accepted
- Sep 3, 7:10 PM ET
- Size
- 6.5 KB